Bialecki R - Search Results

1

Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist.

Wilson C, Hunt SJ, Tang E, Wright N, Kelly E, Palmer S, Heys C, Mellor S, James R, Bialecki R. Wilson C, et al. Among authors: bialecki r. J Pharmacol Exp Ther. 1999 Sep;290(3):1085-91. J Pharmacol Exp Ther. 1999. PMID: 10454481

2

ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.

Bialecki RA, Fisher CS, Abbott BM, Barthlow HG, Caccese RG, Stow RB, Rumsey J, Rumsey W. Bialecki RA, et al. Pulm Pharmacol Ther. 1999;12(5):303-12. doi: 10.1006/pupt.1999.0211. Pulm Pharmacol Ther. 1999. PMID: 10545286

3

Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.

Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K. Rumsey WL, et al. Among authors: bialecki ra. J Pharmacol Exp Ther. 2001 Jul;298(1):307-15. J Pharmacol Exp Ther. 2001. PMID: 11408556

4

Chronic hypoxia increases staurosporine sensitivity of pulmonary artery smooth muscle to endothelin-1.

Bialecki RA, Fisher CS, Murdoch WW, Barthlow HG. Bialecki RA, et al. Pulm Pharmacol Ther. 1998 Apr-Jun;11(2-3):159-63. doi: 10.1006/pupt.1998.0131. Pulm Pharmacol Ther. 1998. PMID: 9918749

5

A novel orally active endothelin-A receptor antagonist, ZD1611, prevents chronic hypoxia-induced pulmonary hypertension in the rat.

Bialecki RA, Stinson-Fisher C, Murdoch W, Bertelsen D, Desiato M, Rumsey W. Bialecki RA, et al. Chest. 1998 Jul;114(1 Suppl):91S. doi: 10.1378/chest.114.1_supplement.91s. Chest. 1998. PMID: 9676649 No abstract available.

6

Functional comparison of endothelin receptors in human and rat pulmonary artery smooth muscle.

Bialecki RA, Fisher CS, Murdoch WW, Barthlow HG, Bertelsen DL. Bialecki RA, et al. Am J Physiol. 1997 Feb;272(2 Pt 1):L211-8. doi: 10.1152/ajplung.1997.272.2.L211. Am J Physiol. 1997. PMID: 9124371

7

Hypoxic exposure time dependently modulates endothelin-induced contraction of pulmonary artery smooth muscle.

Bialecki RA, Fisher CS, Murdoch WW, Barthlow HG, Stow RB, Mallamaci M, Rumsey W. Bialecki RA, et al. Am J Physiol. 1998 Apr;274(4):L552-9. doi: 10.1152/ajplung.1998.274.4.L552. Am J Physiol. 1998. PMID: 9575873

8

Discovery of novel, orally active dual NK1/NK2 antagonists.

Bernstein PR, Aharony D, Albert JS, Andisik D, Barthlow HG, Bialecki R, Davenport T, Dedinas RF, Dembofsky BT, Koether G, Kosmider BJ, Kirkland K, Ohnmacht CJ, Potts W, Rumsey WL, Shen L, Shenvi A, Sherwood S, Stollman D, Russell K. Bernstein PR, et al. Among authors: bialecki r. Bioorg Med Chem Lett. 2001 Oct 22;11(20):2769-73. doi: 10.1016/s0960-894x(01)00572-8. Bioorg Med Chem Lett. 2001. PMID: 11591520

9

Pre-clinical validation of a novel alpha-7 nicotinic receptor radiotracer, [(3)H]AZ11637326: target localization, biodistribution and ligand occupancy in the rat brain.

Maier DL, Hill G, Ding M, Tuke D, Einstein E, Gurley D, Gordon JC, Bock MJ, Smith JS, Bialecki R, Eisman M, Elmore CS, Werkheiser JL. Maier DL, et al. Among authors: bialecki r. Neuropharmacology. 2011 Jul-Aug;61(1-2):161-71. doi: 10.1016/j.neuropharm.2011.03.024. Epub 2011 Apr 7. Neuropharmacology. 2011. PMID: 21497612

10

Pharmacological characterization of mucin secretion from CHO-K1-hNK(1)R cells.

Caccese R, Graham A, Bialecki R. Caccese R, et al. Among authors: bialecki r. Neuropeptides. 1999 Jun;33(3):239-43. doi: 10.1054/npep.1999.0030. Neuropeptides. 1999. PMID: 10657498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters